Latest Australian Growth News

DigiCo Infrastructure REIT is using US asset sales to lower leverage and concentrate capital on its Australian data centre pipeline, led by the fully funded 88MW SYD1 project. The strategy comes alongside a $100.8 million statutory loss, higher distributions and FY27 guidance for 15.0 cents per security.

Transurban recorded 3.4% growth in Group average daily traffic in August, with North America again providing the standout performance. The result was positive overall, although Melbourne’s underlying traffic fell once the West Gate Tunnel contribution was removed.

Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.

DigiCo Infrastructure REIT (ASX: DGT) beats FY26 EBITDA guidance with $127 million, appoints Simon Mitchell and Ralph Goninan as Co-Heads, and accelerates its SYD1 data centre expansion amid strong Australian market demand.

oOh!media reported a 1.4% revenue increase to $340.9 million in 1H26 but saw adjusted underlying EBITDA fall 22.5% due to rising fixed rents and soft billboard demand. The company declared a 2 cent interim dividend and agreed to a $1.68 per share takeover scheme with I Squared Capital.

Macro Metals has agreed in principle to sell its Agbaja Iron Ore Project in Nigeria to RSIN Nigeria Limited for US$5.67 million, allowing the company to refocus on Western Australian operations.

ECP Emerging Growth Limited reported a sharp 20.4% portfolio decline in FY2026 amid sector-wide challenges, yet declared a fully franked final dividend of 3.15 cents per share, supported by realised gains and reserves.

Premier Investments trims FY26 Premier Retail EBIT forecast to $176 million, citing tough trading conditions and announces exit from UK Peter Alexander stores while focusing on Australian growth and loyalty programs.

EROAD has appointed David Leach as CEO, effective October 2026, aiming to leverage his SaaS scaling expertise to accelerate growth and develop an AI-native platform.

Microba Life Sciences has delivered robust FY26 growth in its core microbiome testing business, with revenues up 92% year-on-year and a new GI Navigator product set for launch in September 2026. The company also announced a $7 million annualised cost reduction program as it advances towards cashflow break-even.

MyEco Group’s FY26 retail sales edged up 0.8% to $15.8 million, powered by a 22.7% surge in Australian branded product sales and a successful launch of certified recycled bin liners at Woolworths.

Adairs posts 3.7% sales growth in FY26 but underlying EBIT dips 1.3%, weighed down by Focus on Furniture's ongoing struggles and a substantial non-cash impairment.